Michelson Diagnostics made a big impact at BiOS09 with its ‘VivoSight’ prototype hand-held Optical Coherence Tomography (OCT) scanner. The SPIE BiOS show is the largest annual exhibition and conference on biomedical optics, held this year in San Jose, California 24th-29th January.
The company plans to launch the VivoSight scanner with clinical approvals in late spring 2009, but the exhibition gave excited customers an opportunity to preview its capabilities.
“We were kept very busy with demonstrations of VivoSight, from the moment the show opened, to the very last minute of the show”, said Dr Gordon McKenzie, Medical Applications Director, “and we have received a lot of enquiries, especially for dermal and oral applications”.
Many customers commented that they were attracted by Michelson’s ability to demonstrate the best commercially available OCT images in such a compact probe, designed from the outset for clinical applications. The image quality is enabled by Michelson’s unique ‘Multi-Beam OCT’ technology, which provides double the image resolution available from single-beam OCT scanners – 10 µm lateral resolution throughout the 1 mm depth of field.
Contact email for further details: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
![]() | Michelson Diagnostics’ busy stand at BiOS09 |
![]() | Prototype VivoSight Hand-held OCT probe (non-endoscope version) |
![]() | Prototype VivoSight Hand-held OCT probe (endoscopic version) |